Actinium Pharmaceuticals, Inc. (ATNM)
1.40
-0.03
(-2.10%)
USD |
NYAM |
Dec 08, 16:00
1.41
+0.01
(+0.71%)
After-Hours: 20:00
Actinium Pharmaceuticals Shareholders Equity (Quarterly): 13.78M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Arcus Biosciences, Inc. | 436.00M |
| Apyx Medical Corp. | 5.848M |
| AbbVie, Inc. | -2.642B |
| Karyopharm Therapeutics, Inc. | -269.26M |
| NovaBay Pharmaceuticals, Inc. | 1.634M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 56.15M |
| Total Liabilities (Quarterly) | 42.37M |
| Debt to Equity Ratio | 0.0829 |
| Current Ratio | 7.955 |
| Net Debt Paydown Yield | 0.28% |